1. Home
  2. DBVT vs COCH Comparison

DBVT vs COCH Comparison

Compare DBVT & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • COCH
  • Stock Information
  • Founded
  • DBVT 2002
  • COCH 1995
  • Country
  • DBVT France
  • COCH United States
  • Employees
  • DBVT N/A
  • COCH N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • COCH Blank Checks
  • Sector
  • DBVT Health Care
  • COCH Finance
  • Exchange
  • DBVT Nasdaq
  • COCH Nasdaq
  • Market Cap
  • DBVT 67.8M
  • COCH 64.4M
  • IPO Year
  • DBVT N/A
  • COCH N/A
  • Fundamental
  • Price
  • DBVT $3.12
  • COCH $1.82
  • Analyst Decision
  • DBVT Strong Buy
  • COCH Strong Buy
  • Analyst Count
  • DBVT 2
  • COCH 4
  • Target Price
  • DBVT $22.50
  • COCH $8.00
  • AVG Volume (30 Days)
  • DBVT 363.4K
  • COCH 43.7K
  • Earning Date
  • DBVT 11-06-2024
  • COCH 11-14-2024
  • Dividend Yield
  • DBVT N/A
  • COCH N/A
  • EPS Growth
  • DBVT N/A
  • COCH N/A
  • EPS
  • DBVT N/A
  • COCH N/A
  • Revenue
  • DBVT $12,515,000.00
  • COCH $278,000.00
  • Revenue This Year
  • DBVT N/A
  • COCH N/A
  • Revenue Next Year
  • DBVT $2,860.00
  • COCH $17.09
  • P/E Ratio
  • DBVT N/A
  • COCH N/A
  • Revenue Growth
  • DBVT 125.54
  • COCH 15.35
  • 52 Week Low
  • DBVT $0.44
  • COCH $1.08
  • 52 Week High
  • DBVT $4.50
  • COCH $11.46
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 60.52
  • COCH 38.78
  • Support Level
  • DBVT $3.02
  • COCH $1.64
  • Resistance Level
  • DBVT $3.93
  • COCH $2.06
  • Average True Range (ATR)
  • DBVT 0.31
  • COCH 0.20
  • MACD
  • DBVT -0.06
  • COCH -0.02
  • Stochastic Oscillator
  • DBVT 6.76
  • COCH 38.24

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

Share on Social Networks: